Regencell Bioscience Holdings Limited
RGC
Classement en actions
#3457
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Prix de l'action
$9.86
Capitalisation boursière
$4.89B
Changement (1 jour)
-8.70%
Changement (1 an)
-37.40%
Pays
HK
Échange Regencell Bioscience Holdings Limited (RGC)
Catégorie
Healthcare
Historique du prix de l'action pour Regencell Bioscience Holdings Limited (RGC)
Prix de clôture le plus élevé : $8.35 le 2026-10-01
Prix de clôture le plus bas : $0.24 le 2021-07-01
Prix de clôture le plus bas : $0.24 le 2021-07-01
Historique du prix de l'action de Regencell Bioscience Holdings Limited de 2021 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -1.78% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
